RADIENT PHARMACEUTICALS Corp

Formerly NYSE American: RPC
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K/A 18 pages Onko-Sure Dr-70 License Agreement
12/34/56
EX-10.1
from 8-K 14 pages Onko-Sure Dr-70 License Agreement
12/34/56
EX-10.1
from 8-K/A 1 page Amendment to License Agreement
12/34/56
EX-10.1
from 8-K/A 1 page Amendment to License Agreement
12/34/56
EX-10.1
from 8-K 14 pages License Agreement
12/34/56
EX-10.1
from 8-K 11 pages Via Federal Express and Electronic Mail To: Iroquois Master Fund Ltd. Cranshire Capital, L.P. Freestone Advantage Partners, LP Bristol Investment Fund, Ltd. Kingsbrook Opportunities Master Fund LP Alpha Capital Anstalt Whalehaven Capital Fund, Ltd
12/34/56
EX-10.96
from S-1/A 3 pages RADIENT Phamaceuticals Corporation
12/34/56
EX-10.95
from S-1/A 2 pages Amendment to Consulting Agreement
12/34/56
EX-10.94
from S-1/A 7 pages Consulting Agreement
12/34/56
EX-10.93
from S-1/A 2 pages Amendment to Consulting Agreement
12/34/56
EX-10.92
from S-1/A 4 pages Consulting Agreement
12/34/56
EX-10.91
from S-1/A 2 pages Amendment to Investment Advisory Agreement
12/34/56
EX-10.90
from S-1/A 7 pages Investment Advisory Agreement Between RADIENT PHARMACEUTICALS Corp., and Galileo Asset Management SA
12/34/56
EX-10.89
from S-1/A 2 pages Amendment to Advisory Agreement
12/34/56
EX-10.88
from S-1/A 5 pages Garden State Securities Inc
12/34/56
EX-10.87
from S-1/A 2 pages Amendment to Consulting Agreement
12/34/56
EX-10.86
from S-1/A 6 pages Consulting Agreement for Investor Relations Services Between
12/34/56
EX-10.85
from S-1/A 2 pages Amendment to Consulting Agreement
12/34/56
EX-10.84
from S-1/A 6 pages Consulting Agreement for Investor Relations Services Between
12/34/56
EX-10.83
from S-1/A 3 pages Debenture Amendment
12/34/56